Cytokinetics
CYTK
#2437
Rank
C$10.50 B
Marketcap
C$85.90
Share price
1.64%
Change (1 day)
42.00%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -C$1.06 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are C$87.21 Million. In 2024 the company made an earning of -C$0.8 Billion a decrease over its 2023 earnings that were of -C$0.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$1.06 Billion32.2%
2024 -C$0.8 Billion12.03%
2023 -C$0.72 Billion35.3%
2022 -C$0.53 Billion80.65%
2021 -C$0.3 Billion69.15%
2020 -C$0.18 Billion4.6%
2019 -C$0.17 Billion14.49%
2018 -C$0.15 Billion-16.83%
2017 -C$0.18 Billion-812.8%
2016 C$24.3 M-147.81%
2015 -C$50.85 Million156.05%
2014 -C$19.86 Million-56.56%
2013 -C$45.72 Million-16.48%
2012 -C$54.74 Million-15.65%
2011 -C$64.9 Million-3.24%
2010 -C$67.07 Million-308.68%
2009 C$32.13 M-141.87%
2008 -C$76.75 Million0.21%
2007 -C$76.59 Million-7.91%
2006 -C$83.17 Million37.42%
2005 -C$60.52 Million16.13%
2004 -C$52.11 Million-19.29%
2003 -C$64.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.17 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-C$42.11 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$90.55 M-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-C$0.37 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$5.97 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA